Patient biology guides our decisions and we choose the path of maximum patient impact.

We always prioritize action over inertia, even when navigating complex shifts.

We execute all the way and don’t leave work half-finished.

We optimize collaboration over individual agendas, egos, or functional silos to succeed.

We embrace adversity and emerge stronger from the challenges we overcome.

OncoPrecision is a precision oncology company engineering first-in-class ADCs and bispecific antibodies for hard-to-treat cancers.

We start where other drugs fail — studying how cancer cells evade treatment — then engineer precision therapeutics to exploit those vulnerabilities. By combining Patient Micro-Avatars™ (translational patient-derived ex vivo phenotypic models) with AI-driven target validation, our discovery engine surfaces biology that population-level datasets miss — giving every program a structural advantage from day one.

Biotechnology

Therapeutics

OncoPrecision

OncoPrecision's headquarters in New York, NY, United States

Operations

��

People (1)

Jobs (0)

Other teams

Biology

Antibody Discovery & Development

Clinical Research

Founders

Admin

��������